RGS16 and esophageal squamous cell carcinoma: Zhang et al. demonstrated that RGS16 could boost YAP activity by interfering with the interaction between LATS1 and MST1, thereby facilitating the proliferation and migration of esophageal cancer cells (ESCC) [25].